In a phase II, placebo-controlled trial, patients with severe sepsis and high predicted risk of death that were treated with eritoran showed a trend towards lower mortality (Tidswell et al. 2010 ).
1
—
—
In a phase II, placebo-controlled trial, patients with severe sepsis and high predicted risk of death that were treated with eritoran showed a trend towards lower mortality (Tidswell et al. 2010 ).